| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |